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能够不同程度地抑制10 pS氯通道的活性，通道开放概率（NPo）分别从0.9894 ± 
0.1127降低至0.8469 ± 0.08855（n = 6），0.5989 ± 0.06853（n = 12，P < 0 .01），0.5600 
± 0.06827（n = 5，P < 0.05）和0.4754 ± 0.1024（n = 7，P < 0.01）。 
二、浴液中加入10 μM的NO的清除剂Carboxy-PTIO，其本身对通道活性没
有显著影响（NPo从1.133 ± 0.2645 变为1.063 ± 0.1773，n = 6），却能阻断SNAP
（5 μM）对10 pS氯通道的抑制作用（NPo = 0.9534 ± 0.1872，n = 6）。 
三、浴液中加入 10 μM 的可溶性鸟苷酸环化酶（sGC）抑制剂 ODQ，其本
身对通道活性没有显著影响（NPo 从 1.068 ± 0.1105 变为 1.130 ± 0.1022，n = 5），
却能阻断 SNAP（5 μM）对 10 pS 氯通道的抑制作用（NPo = 0.9542 ± 0.1024，n 
= 5）；同样，浴液中加入 10 μM sGC 的另一种抑制剂 LY-83583，其本身同样对
通道活性没有显著影响（NPo 从 1.146 ± 0.2348 变为 1.145 ± 0.1956，n = 5），并
也能阻断 SNAP（5 μM）对 10 pS 氯离子通道的抑制作用（NPo = 0.9884 ± 0.2130，
n = 5）。此外，浴液中加入 100 μM cGMP 的类似物 8-BrcGMP，也能显著抑制 10 















0.05，n = 6）。 
四、浴液中加入 5 μM 蛋白激酶 G（PKG）的拮抗剂 KT5823，其本身对通
道活性没有显著影响（NPo 从 1.182 ± 0.1400 变为 1.139 ± 0.2323，n = 5），却能
阻断 SNAP（5 μM）对 10 pS 氯通道的抑制作用（NPo = 1.046 ± 0.1264，n = 5）；
而加入 100 nM 的磷酸二酯酶 II（PDEII）的拮抗剂 BAY-60-7550，既不能对通道
活性产生显著影响（NPo 从 1.007 ± 0.09465 变为 0.9394 ± 0.09547，n = 5），也不
能能阻断 SNAP（5 μM）对 10 pS 氯通道的抑制作用（NPo = 0.5584 ± 0.05900，
P < 0.05，n = 5）。 
五、浴液中加入 0.5 mM NO 内源性供体 L-Arg 可以显著抑制小鼠肾脏髓袢
升支粗段管周膜侧 10 pS 氯通道的活性（NPo 从 1.132 ± 0.2683，降到了 0.4841 ± 
0.07017，P < 0.05，n = 5）。 
六、髓袢升支粗段组织与 10 和 100 nM 的血管紧张素的 2 型受体（AT2R）
激动剂 CGP 42112A 在 37℃水浴锅中孵育 5min，能够显著促进 eNOS 1177 位 Ser
的磷酸化，而不影响总 eNOS 的表达；髓袢升支粗段组织与 10 nM 的 CGP 42112A
在 37℃水浴锅中孵育 5、15 和 30 min 都可以显著促进 eNOS 1177 位 Ser 的磷酸
化，同时并不影响总 eNOS 的表达。 
结论： 
一、NO 的外源性供体 SNAP 可以显著抑制小鼠肾脏髓袢升支粗段管周膜侧
10 pS Cl-通道的活性，并呈现一定的剂量依赖性。 
二、SNAP对小鼠肾脏髓袢升支粗段管周膜侧 10 pS Cl-通道活性的抑制作用，
是通过 TAL 中的 cGMP-PKG 途径介导的。 
三、NO 的内源性供体 L-Arg 也可以显著抑制小鼠肾脏髓袢升支粗段管周膜
侧 10 pS Cl-通道的活性。 
四、血管紧张素的 2 型受体的激动剂 CGP 42112A 可以促进 TAL 中 eNOS 
1177 位 Ser 的磷酸化。 
以上结果暗示，激活血管紧张素 2 型受体可促进 eNOS 磷酸化，合成 NO；
合成的 NO 通过 cGMP 依赖性 PKG 信号通路可抑制肾脏髓袢升支粗段管周膜侧
10 pS Cl-通道的活性，从而参与 Cl-稳态平衡的调节。 

















Backgrounds: The thick ascending limb (TAL) is responsible for the reabsorption of 
20-25% of the filtered salt load and plays a key role in the urinary concentrating 
mechanism. Approximately 20-25% of reabsorbed Na and Cl enter epithelial cells in 
the TAL through apical type II Na+-K+-2Cl- cotransporter (NKCC2) and leave the cell 
primarily through basolateral Na+-K+-ATPase and Cl- channels, respectively. NO has 
been shown to inhibit apical NKCC2 activity, thereby reducing Cl- reabsorption. In 
order to maintain the homeostasis of the TAL, if the absorption of Cl- is reduced in 
apical membrane, the excrete of the basolateral membrane should be reduced. The 10 
pS Cl- channel is the most important ion channel of Cl- on the basolateral membrane,  
so we deduce that the channel activity will be regulated by NO. 
Objectives: We use the cell attached patch clamp technique to observe whether NO 
could inhibit TAL basolateral 10 pS Cl- channel activity and reduce the Cl- 
reabsorption in the TAL. hen we want to reveal the role of cGMP in this process,, and 
improve the process of signal transduction pathway. In addition, we want to know the 
effect of AT2R agonist on eNOS phosphorylation by western blot technique. 
Results:  
1. Addition of NO exogenous donor SNAP inhibited the basolateral 10 pS Cl- 
channels activity, defined by NPo. Dose-response curve of SNAP’s effect showing 
that 2.5, 5, 7.5 and 10 μM SNAP significantly inhibited channel activity, NPo from  
0.9894 ± 0.1127 to 0.8469 ± 0.08855 (n = 6), 0.5989 ± 0.06853(n = 12, P < 0.01), 
0.5600 ± 0.06827 (n = 5, P < 0.05) and 0.4754 ± 0.1024 (n = 7, P < 0.01). 
2. Addition of NO scavenger Carboxy-PTIO (10 μM) did not significantly affect 
the basolateral 10 pS Cl- channels activity, defined by NPo, from 1.133 ± 0.2645 to 
1.063 ± 0.1773 (n = 6). However, it completely abolished the effect of SNAP (5 μM)  
on the 10 pS Cl- channels (NPo = 0.9534 ± 0.1872, n = 6). Application of SNAP 
failed to inhibit the Cl- channels in the presence of Carboxy-PTIO.  















channels, defined by NPo, from 1.068 ± 0.1105 to 1.130 ± 0.1022 (n = 5). However, it 
completely abolished the effect of SNAP (5 μM) on the 10 pS Cl- channels (NPo = 
0.9542 ± 0.1024, n = 5). Application of SNAP failed to inhibit the Cl- channels in the 
presence of ODQ. Similarly, inhibition of sGC with 10 μM LY-83583 had no 
significant effect on the Cl- channels, defined by NPo, from 1.146 ± 0.2348 to 1.145 ± 
0.1956 (n = 5). However, it completely abolished the effect of SNAP (5 μM) on the 10 
pS Cl- channels(NP = 0.9884 ± 0.2130, n = 5). Application of SNAP failed to inhibit 
the Cl- channels in the presence of LY-83583. In addition, cGMP analog 8-BrcGMP 
(100 μM) could inhibit the basolateral 10 pS Cl- channels activity, NPo from 1.173 ± 
0.2794 to 0.4350 ± 0.07194 (P < 0.05, n = 6).  
4. Inhibition of PKG with 5 μM KT5823 had no significant effect on the Cl- 
channels (NPo from 1.182 ± 0.1400 to 1.139 ± 0.2323, n = 5). However, it completely 
abolished the effect of SNAP on the 10 pS Cl- channels(NPo = 1.046 ± 0.1264, n = 5). 
Application of SNAP failed to inhibit the Cl- channels in the presence of KT5823. 
Similarly, inhibition of PDEII with 100 nM BAY-60-7550 had no significant effect on 
the Cl- channels (NPo from 1.007 ± 0.09465 to 0.9394 ± 0.09547, n = 5), meanwhile, 
it couldn’t block the inhibition effect of SNAP on the 10 pS Cl- channels (NPo = 
0.5584 ± 0.05900, P < 0.05, n = 5). Application of SNAP can still inhibit the Cl- 
channels in the presence of BAY-60-7550. 
5. Addition of NO endogenous donor L-Arg inhibited the basolateral 10 pS Cl- 
channels activity, defined by NPo, from 1.132 ± 0.2683 to 0.4841 ± 0.07017 (P < 0.05, 
n = 5). 
6. Outer medullary tissue (TAL) with 10 and 100 nM of AT2R agonist CGP 
42112A in 37℃  water incubation for 5 min, could significantly promote the 
phosphorylation of eNOS Ser1177 and does not affect the expression of total NOS; 
Outer medullary tissue (TAL) with 10 nM CGP 42112A in 37℃ water incubation 5, 
15 and 30 min can significantly promote the phosphorylation of eNOS Ser1177, also 
does not affect the expression of total eNOS. 
Conclusion:  















ascending limb basolateral 10 pS Cl- channels, which showed a dose dependent 
manner. 
2. The inhibition of SNAP on mice kidney thick ascending limb basolateral 10 
pS Cl- channels activity is achieved by cGMP-PKG pathway in the TAL. 
3. NO endogenous donor L-Arg can significantly inhibit the mice kidney thick 
ascending limb basolateral 10 pS Cl- channels. 
4. Angiotensin type 2 receptor agonist CGP 42112A can promote the 
phosphorylation of eNOS Ser1177 in TAL. 
Key words: patch-clamp technique; nitric oxide; 10 pS Cl- channel; endothelial nitric 
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